Sort   by:  
 Page size 
UnknownColorectal cancer: Overcoming resistance to anti-EGFR therapy - where do we stand?
Not available
S-EPMC7493690 | biostudies-literature
UnknownBiomarker in Colorectal Cancer.
Not available
S-EPMC4955946 | biostudies-literature
UnknownUnderstanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer.
Not available
S-EPMC4799732 | biostudies-literature
UnknownCDX2 as a Prognostic Biomarker in Colon Cancer.
Not available
S-EPMC7521111 | biostudies-literature
UnknownIrinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis.
Not available
S-EPMC10252545 | biostudies-literature
UnknownSafety and Tolerability of c-MET Inhibitors in Cancer.
Not available
S-EPMC7491978 | biostudies-literature
UnknownPharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives.
Not available
S-EPMC8442855 | biostudies-literature
ProteomicsInteractome of C-terminally truncated CDK6
Pre/pro-B-cell lines were generated from bone marrow cells of Cdk6-/- mice by retroviral overexpression of the BCR-ABL (p185) fusion oncogene. These cell lines were transduced with constructs expressing HA-tagged versions of wildtype Cdk6 or of a C-terminally truncated variant of Cdk6 (HA-Cdk6-ΔC)....
ORGANISM(S): Mus musculus (Mouse) 
2024-12-19 | PXD058474 | Pride
Cyclin-dependent kinase 6 C-terminus Ip mass spec 
UnknownPotential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients.
Not available
S-EPMC8126324 | biostudies-literature
UnknownClinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients.
Not available
S-EPMC7505126 | biostudies-literature
Sort   by:  
 Page size